Buchta Christoph, Benka Bernhard, Delatour Vincent, Faé Ingrid, Griesmacher Andrea, Hellbert Karina, Huggett Jim, Kaiser Patricia, Kammel Martin, Kessler Anja, Kessler Harald H, Müller David, Rosendahl Jennifer, Scheiblauer Heinrich, Schweiger Christian R, Zeichhardt Heinz, Cobbaert Christa M
Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA), Vienna, Austria.
Austrian Agency for Health and Food Safety, Vienna, Austria.
Clin Chem Lab Med. 2024 Oct 14;63(4):656-669. doi: 10.1515/cclm-2024-1066. Print 2025 Mar 26.
European Union (EU) regulations on diagnostics (IVD) and on serious cross-border threats to health provide for the establishment of European Reference Laboratories (EURLs) and their harmonization and cooperation with National Reference Laboratories (NRLs). While the EURLs under the IVD Regulation will be operational by 1 October 2024, the EURLs under the Regulation on serious cross-border threats to health will be operational by January 2025. Although NRLs may have been operating for a long time on the basis of national legislation, they should now cooperate with each other and with EURLs in a network of centers of excellence for the authorization and post-market surveillance of IVDs and for the epidemiological surveillance and control of communicable diseases. The term "reference laboratory" has long been used colloquially to refer to many kinds of laboratories, regardless of their tasks, competencies, responsibilities and designation. A literature search and analysis confirmed this by showing that a considerable proportion of scientific publications in 2024 use the term "reference laboratory" inappropriately. In order to clarify the roles and functioning of EURLs and NRLs, we have evaluated the relevant current EU provisions and compared the findings with those of reference laboratories designated by other organizations, calibration (reference) laboratories and referral laboratories, which are simply referred to as "reference laboratories". With the forthcoming implementation of the EU regulations, at least the goals of providing safe and high-quality IVDs and adequate public health surveillance for communicable diseases appear to be achievable.
欧盟关于诊断医疗器械(IVD)以及对健康构成严重跨境威胁的法规规定了设立欧洲参考实验室(EURLs),并规定了它们与国家参考实验室(NRLs)的协调与合作。虽然IVD法规下的EURLs将于2024年10月1日开始运作,但关于对健康构成严重跨境威胁的法规下的EURLs将于2025年1月开始运作。尽管NRLs可能已经根据国家立法运作了很长时间,但它们现在应该在一个卓越中心网络中相互合作,并与EURLs合作,以进行IVD的授权和上市后监督以及传染病的流行病学监测和控制。长期以来,“参考实验室”一词一直被通俗地用来指代许多种类的实验室,而不论其任务、能力、职责和指定情况如何。一项文献检索和分析证实了这一点,该分析表明,2024年相当一部分科学出版物对“参考实验室”一词的使用不当。为了阐明EURLs和NRLs的作用和运作方式,我们评估了欧盟目前的相关规定,并将结果与其他组织指定的参考实验室、校准(参考)实验室和转诊实验室(简称为“参考实验室”)的结果进行了比较。随着欧盟法规的即将实施,至少提供安全和高质量IVD以及对传染病进行充分公共卫生监测的目标似乎是可以实现的。